Korea United Pharm Inc
KRX:033270

Watchlist Manager
Korea United Pharm Inc Logo
Korea United Pharm Inc
KRX:033270
Watchlist
Price: 20 550 KRW -1.44%
Market Cap: 302.3B KRW
Have any thoughts about
Korea United Pharm Inc?
Write Note

Korea United Pharm Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Korea United Pharm Inc
Total Receivables Peer Comparison

Comparables:
000100
326030
008930
128940
S
000250

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Korea United Pharm Inc
KRX:033270
Total Receivables
â‚©49.3B
CAGR 3-Years
4%
CAGR 5-Years
1%
CAGR 10-Years
2%
Yuhan Corp
KRX:000100
Total Receivables
â‚©628B
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
11%
SK Biopharmaceuticals Co Ltd
KRX:326030
Total Receivables
â‚©115.8B
CAGR 3-Years
109%
CAGR 5-Years
138%
CAGR 10-Years
N/A
Hanmi Science Co Ltd
KRX:008930
Total Receivables
â‚©94.1B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
-1%
Hanmi Pharm Co Ltd
KRX:128940
Total Receivables
â‚©188.7B
CAGR 3-Years
-1%
CAGR 5-Years
-4%
CAGR 10-Years
-3%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Total Receivables
â‚©72.5B
CAGR 3-Years
23%
CAGR 5-Years
12%
CAGR 10-Years
8%

See Also

What is Korea United Pharm Inc's Total Receivables?
Total Receivables
49.3B KRW

Based on the financial report for Jun 30, 2024, Korea United Pharm Inc's Total Receivables amounts to 49.3B KRW.

What is Korea United Pharm Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
2%

Over the last year, the Total Receivables growth was 5%. The average annual Total Receivables growth rates for Korea United Pharm Inc have been 4% over the past three years , 1% over the past five years , and 2% over the past ten years .

Back to Top